Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Circadian skin pH gates IL-33 and remote food sensitization.
Journal: The Journal of investigative dermatology
Published: March 19, 2026
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: September 17, 2025
Synergistic effect of thermoneutral housing and chronotherapeutic PD-1 blockade overcomes melanoma resistance.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 09, 2025
The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer.
Journal: PloS one
Published: September 12, 2024
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.
Journal: Cancer immunology research
Published: April 08, 2022
Development and evaluation of a novel MR-compatible pelvic end-to-end phantom.
Journal: Journal of applied clinical medical physics
Published: May 22, 2018
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
Journal: NPJ genomic medicine
Published: August 19, 2017
Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.
Journal: Cell reports
Published: October 13, 2016
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.
Journal: Science translational medicine
Published: August 03, 2016
Last Updated: 09/26/2026